A qualitative research exploring the experiences of patients receiving immune checkpoint inhibitors for advanced lung cancer

被引：0
|
作者：
Yunxia Hou
Yingge Hou
Jing Li
Lijuan Yu
Ling Yan
机构：
[1] Key Laboratory of Cancer Prevention and Therapy,Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer
[2] Tianjin Medical University,undefined
来源：
Supportive Care in Cancer | 2023年 / 31卷
关键词：
Immune checkpoint inhibitors; Stage IV non-small cell lung cancer; Quality of life; Qualitative research; Supportive care;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Cardiotoxicity of Immune Checkpoint Inhibitors in Patients with Lung Cancer
    Chitturi, Kalyan R.
    Araujo-Gutierrez, Raquel
    McLean, Edward T.
    Xu, Jiaqiong
    Bhimaraj, Arvind
    Guha, Ashrith
    Hussain, Imad
    Trachtenberg, Barry H.
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S50 - S50
  • [22] Immune checkpoint inhibitors in special populations. A focus on advanced lung cancer patients
    Escoin-Perez, Corina
    Blasco, Sara
    Juan-Vidal, Oscar
    LUNG CANCER, 2020, 144 : 1 - 9
  • [23] Identification of C-PLAN index as a novel prognostic predictor for advanced lung cancer patients receiving immune checkpoint inhibitors
    Wang, Jiaxin
    Guo, Huaijuan
    Yang, Jingjing
    Mao, Jingxian
    Wang, Ying
    Yan, Xuebing
    Guo, Hong
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [24] THYROID DYSFUNCTION IN PATIENTS WITH LUNG CANCER RECEIVING IMMUNE CHECKPOINT INHIBITORS: A RETROSPECTIVE, OBSERVATIONAL STUDY
    Kulkarni, Ajinkya
    Baralo, Bohdan
    Kulkarni, Mrunal
    Ellangovan, Rithikaa
    Thirumaran, Rajesh
    CHEST, 2020, 158 (04) : 1465A - 1465A
  • [25] Inpatient and ED Use Among Melanoma and Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
    Tay, Djin L.
    Dubose, Kline
    Meeks, Huong
    Guo, Jia-Wen
    Feldner, Katie
    Alekhina, Natalya
    Sheng, Xiaoming
    Chipman, Jonathan
    Ellington, Lee
    Hashibe, Mia
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2024, 67 (05) : E826 - E827
  • [26] Research progress in immune checkpoint inhibitors for lung cancer in China
    Gan, Jiadi
    Huang, Yihua
    Fang, Wenfeng
    Zhang, Li
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [27] Biomarkers for immune checkpoint inhibitors in advanced nonsmall cell lung cancer
    Pirker, Robert
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (01) : 24 - 28
  • [28] Pharmaceutical Care Contributes to the Advanced Management of Patients Receiving Immune Checkpoint Inhibitors
    Saito, Yoshitaka
    Uchiyama, Kazuki
    Sakamoto, Tatsuhiko
    Yamazaki, Kojiro
    Kubota, Kosei
    Takekuma, Yoh
    Komatsu, Yoshito
    Sugawara, Mitsuru
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2020, 43 (12) : 1969 - 1974
  • [29] Immune checkpoint inhibitors in lung cancer
    Koleczko, S.
    Wolf, J.
    INTERNIST, 2020, 61 (07): : 676 - 681
  • [30] AKI in Patients Receiving Immune Checkpoint Inhibitors
    Perazella, Mark A.
    Sprangers, Ben
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (07): : 1077 - 1079
12345